• stephanromeijn
• March 12, 2025
• • News
• • gleamer
  • mri
  • acquisition
  • pixyl

Following the recent launch of BreastView, its CE-marked AI application for breast cancer detection, Gleamer is further expanding its product portfolio with the acquisition of Pixyl and Caerus Medical.

Pixyl.Neuro leverages AI for detecting abnormalities in brain MRI scans, while Caerus Medical’s LumbAI supports the diagnosis of lumbar pathologies.

With these additions, Gleamer now offers AI solutions across all core imaging modalities, including x-ray, mammography, CT, and MRI.

Read full press release